Worldwide Transcatheter Treatment Procedures and Heart Valve Industry to 2025 - Major Developments Influencing the Market - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Transcatheter Treatment: Procedures and Heart Valve Market" report has been added to ResearchAndMarkets.com's offering.

Transcatheter treatment includes procedure types such as TAVR, TAVI, TMVR and TMVI. Transcatheter procedure approaches include transfemoral, transapical and transaortic procedures. This report is an analytical business tool with the primary purpose of providing a thorough evaluation of the global market for transcatheter treatment for heart valve diseases.

The Report Includes

• 27 data tables and 26 additional tables
• Descriptive overview of the global market for key transcatheter treatment procedures, heart valve systems, and techniques used for the treatment of valvular diseases
• Analyses of the global market trends, with data from 2019-2020, and projections of five-year compound annual growth rates (CAGRs) through 2025
• Estimation of the actual market size and revenue forecast for transcatheter treatment procedures, and their corresponding market share analysis based on product type, treatment procedure and other key market segments, with major geographic regions and countries involved
• Identification of promising new transcatheter techniques and devices still in the development and testing stages, and the probability of their successful commercialization in the next five years
• Market forecast and market potential for transcatheter treatment procedures based on pipeline devices, on account of their estimated probability of commercial launch
• Assessment of the impact of demographic, economic, and other factors that will drive future demand for the transcatheter treatment devices and technologies market

Key Topics Covered:

Chapter 1 Introduction

Chapter 2 Summary and Highlights

Chapter 3 Structural Heart Valve Disease

• Disease Overview
• Spectrum of Structural Heart Disease
• Valvular Heart Disease
• Symptoms and Risk Factors of Structural Heart Disease
• Causes of Structural Heart Disease
• Rheumatic Fever
• Mitral Valve Prolapse
• Peripheral Artery Disease
• Cardiovascular Disease
• Aortic Aneurysm
• Obesity
• Diagnosis of Structural Heart Disease
• Treatment of Structural Heart Disease
• Management Through Medication
• Surgical Intervention: Heart Valve Repair and Replacement
• Tobacco Smoking and Heart Disease
• Aging, Gender and Structural Heart Diseases
• Global Demographics
• U.S. Demographics
• European Demographics
• Japanese Demographics
• Current Challenges and Future Directions

Chapter 4 Aortic Valve Disease

• Disease Overview
• Types of Aortic Stenosis
• Acquired Aortic Stenosis
• Congenital Aortic Stenosis
• Mild and Moderate Aortic Stenosis
• Severe Aortic Stenosis
• Asymptomatic Aortic Stenosis
• Symptomatic Aortic Stenosis
• Causes, Risk Factors and Symptoms
• Causes
• Symptoms
• Risk Factors
• Epidemiology and Economic Burden
• Diagnosis
• Standard Doppler Echocardiography
• Multimodality Imaging
• Other Techniques
• Treatment
• Open Surgical Treatment (SAVR)
• Transcatheter Treatment (TAVR/TAVI)
• Aortic Valve Repair Versus Aortic Valve Replacement
• Types of Transcatheter Approaches
• Open Surgical Repair (SAVR) versus Transcatheter Treatment (TAVR/TAVI)
• TAVR and TAVI Complications
• Key Marketed and Pipeline Products
• Key Marketed Products
• Key Pipeline/R&D Products
• Unmet Need
• Current Challenges and Future Developments

Chapter 5 Mitral Valve Disease

• Disease Overview
• Types of Mitral Regurgitation
• Disease Origin
• Disease Stage
• Disease Symptoms
• Causes, Risk Factors and Symptoms
• Causes
• Symptoms
• Risk Factors
• Epidemiology and Economic Burden
• Diagnosis
• Standard Echocardiography
• Multimodality Imaging
• Other Techniques
• Treatment
• Open Surgical Treatment (SMVR)
• Transcatheter Treatment (TMVR and TMVI)
• Mitral Valve Repair Versus Mitral Valve Replacement
• Types of Transcatheter Approaches
• Open Surgery (SMVR) Versus Transcatheter Treatment (TMVR/TMVI)
• TMVR Complications
• Key Marketed and Pipeline Products
• Key Marketed Products
• Key Pipeline/R&D Products
• Other Less-Invasive (MIS) Mitral Valve Technologies
• Unmet Need
• Current Challenges and Future Developments

Chapter 6 Tricuspid Valve Disease

• Disease Overview
• Types of Tricuspid Regurgitation
• Primary Tricuspid Regurgitation
• Secondary Mitral Regurgitation
• Causes, Risk Factors and Symptoms
• Causes
• Symptoms
• Epidemiology
• Diagnosis
• Echocardiography and Grading
• Other Techniques
• Treatment
• Medical Treatment
• Tricuspid Valve Surgery
• Key Marketed and Pipeline Products
• Key Marketed Products
• Key Pipeline/R&D Products

Chapter 7 Market Size and Growth Analysis

• Overview
• Market Size and Growth Analysis by Region
• Market Size and Growth Analysis by Segment
• Market Size and Growth Analysis by Procedure Approach
• Market Size and Growth Analysis by Procedure (TAVR/TAVI, TMVR and TTVR)
• Heart Valve Market: Traditional versus Transcatheter Heart Valves
• Market Growth Drivers and Restraints
• Market Growth Drivers
• Market Restraints

Chapter 8 Competitive Landscape

• Overview

Chapter 9 Company Market Strategies

• Market Consolidation in Cardiovascular Device Market
• Mergers and Acquisitions in the Transcatheter Treatment Device Market
• Key Observations Regarding Transcatheter Device Industry
• Future Strategic Landscape

Chapter 10 Regulatory Structure: Medical Devices

• Regulatory Background
• Regulatory Systems for Medical Devices by Region
• U.S.
• European Union (EU)
• Japan

Chapter 11 Pricing and Reimbursement: Medical Devices

• Pricing and Reimbursement Background
• Pricing and Reimbursement for Medical Devices by Region
• United States
• Europe
• Japan

Chapter 12 Conclusions: Outlook for Transcatheter Treatment Devices

• Major Developments Influencing the Market
• Technological Developments
• Demographic and Economic Trends
• Changing Structure of the Healthcare Industry
• Long-Term Outlook for Transcatheter Treatments

Chapter 13 Company Profiles

• Abbott Laboratories
• Biotronik
• Boston Scientific Corp.
• Bracco Spa
• Braile Biomedica
• Cardiac Dimensions Inc.
• Colibri Heart Valve Llc
• Direct Flow Medical Inc.
• Edwards Lifesciences Corp.
• Gorman Cardiovascular Research Group
• Hansen Medical Inc. (Subsidiary Of Auris Health Inc.)
• Highlife Sas
• Jenavalve Technology Inc.
• Medtronic Inc.
• Micro Interventional Devices Inc.
• Microport Scientific
• Mitrassist Ltd.
• MVRX Inc.
• Navigate Cardiac Structures Inc.
• Neovasc Inc.
• St. Jude Medical Inc. (Subsidiary Of Abbott Laboratories)
• Venus Medtech Inc.

Chapter 14 Appendix A: List of Acronyms

Chapter 15 Appendix B: Professional Organizations

For more information about this report visit https://www.researchandmarkets.com/r/e3qd6m